Microporous Polysaccharide Hemosphere Absorbable Hemostat (AristaAH®) use in Re-Operative Cardiac Surgical Procedures

Register or Login to View PDF Permissions
Permissions× For commercial reprint enquiries please contact Springer Healthcare:

For permissions and non-commercial reprint enquiries, please visit to start a request.

For author reprints, please email
Average (ratings)
No ratings
Your rating


Patients undergoing re-operative cardiac surgical procedures present a great challenge with regard to obtaining hemostasis in the surgical field. Adhesions are ever-present and these patients are often on oral anti-coagulants and platelet inhibitors. As part of a well-planned surgical intervention, a systematic approach to hemostasis should be employed to decrease blood transfusion requirement and improve patient outcomes. Topical hemostatic agents can be a great help to the surgeon in achieving surgical field hemostasis and are increasingly being employed. Our approach, to these difficult patients, includes the systematic and planned use of AristaAH, which is a novel hemostatic agent whose use has proven safe and efficacious in our patient population.

Copyright Statement:

The copyright in this work belongs to Radcliffe Medical Media. Only articles clearly marked with the CC BY-NC logo are published with the Creative Commons by Attribution Licence. The CC BY-NC option was not available for Radcliffe journals before 1 January 2019. Articles marked ‘Open Access’ but not marked ‘CC BY-NC’ are made freely accessible at the time of publication but are subject to standard copyright law regarding reproduction and distribution. Permission is required for reuse of this content.

To view the full article in PDF format, please click on the icon above.


  1. Bruckner BA, DiBardino DJ, Ning Q, et al., High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII., J Heart Lung Transplant, 2009;28(8):785–90.
    Crossref | PubMed
  2. Barnard J, Millner R, A review of topical hemostatic agents for use in cardiac surgery, Ann Thorac Surg, 2009;88(4):1377–83.
    Crossref | PubMed
  3. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Brown JR, Despotis GJ, Hammon JW, Reece TB, Saha SP, Song HK, Clough ER; Society of Cardiovascular Anesthesiologists Special Task Force on Blood Transfusion, Shore-Lesserson LJ, Goodnough LT, Mazer CD, Shander A, Stafford-Smith M, Waters J; International Consortium for Evidence Based Perfusion, Baker RA, Dickinson TA, FitzGerald DJ, Likosky DS, Shann KG, 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines, Ann Thorac Surg, 2011;91(3):944–82.
    Crossref | PubMed
  4. Matsushita T, Masuda S, Inoue T, Early experience with combined use of two plant-based hemostatic agents, Ann Thorac Surg, 2010;90(1):327–8.
    Crossref | PubMed